Investment House LLC Indaptus Therapeutics, Inc. Call Options Transaction History
Investment House LLC
- $1.72 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding INDP
# of Institutions
11Shares Held
214KCall Options Held
0Put Options Held
0-
Pine Valley Investments LTD Liability CO Marlton, NJ43.9KShares$361,9090.0% of portfolio
-
Vivaldi Capital Management LP Chicago, IL24KShares$197,7600.0% of portfolio
-
State Street Corp Boston, MA13.1KShares$107,7210.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY3.49KShares$28,7820.0% of portfolio
-
Morgan Stanley New York, NY884Shares$7,2840.0% of portfolio
About Indaptus Therapeutics, Inc.
- Ticker INDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,258,600
- Market Cap $68.1M
- Description
- Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...